IBRXImmunityBio, Inc.Not started yet
Clinical Trial of Ablation Therapy in Participants With Intermediate-Risk Non-Muscle Invasive Papillary Bladder Cancer
Non-muscle Invasive Bladder Cancer (NMIBC)
0Calmworry score, out of 100
No strong warning signs right now. The score counts warning signs; it is not a prediction.
Why this score
No warning signs right now. That's why the score is 0.
Score over time
- Stage
- Phase 2
- Patients
- 20 (planned)
- Started
- Nov 2025
- Main results expected
- Nov 2026
- Fully finished
- Nov 2029
- Results posted
- not yet
What counts as success
The trial's main goal(s), called the “primary outcome.”
Efficacy of Arms A and B at Month 3 and Month 6
Measured over: At Month 3 and Month 6
Changes Tremor has spotted
No changes since Tremor started watching this trial.
Show details (technical version)
Score inputs
- none
Raw record changes
- none yet
Trial ID NCT06829823 · record last updated 2025-10-16 · checked 2026-11-09 15:47 UTC